Results

• All
• Video
• Audio
• Images

• Most recent

1–1 of 1 result for recombinant AAV vectors

• 

  Interim Subretinal Gene Therapy Safety Results in Two Phase 1/2 Open-label, Dose-Escalation Clinical Trials to Treat Achromatopsia

  Lejla Vajzovic, MD, FASRS

  Annual Meeting Talks

  2022